Risk of acquiring Creutzfeldt-Jakob disease from blood transfusions: Systematic review of case-control studies

British Medical Journal

Volumn 321, Issue 7252, 2000, Pages 17-19

  Wilson, Kumanan ^a   Code, Catherine ^b   Ricketts, Maura N ^c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; HUMAN; MEDICAL LITERATURE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0034237683     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.321.7252.17     Document Type: Article

References (18)

1. 1 Krever H. Commission of inquiry on the blood system in Canada. Final report. Canadian Government Publishing: Ottawa, Canada, 1997.
2. 2 Lau J. Meta-analyst program (0.988). Boston, MA: New England Medical Center, 1990.
3. 3 Kondo K, Kuroiwa Y. A case-control study of Creutzfeldt-Jakob disease: association with physical injuries. Ann Neurol 1982;11:377-81.
4. 4 Harries-Jones R, Knight R, Will RG, Cousens S, Smith PG, Mathews WB. Creutzfeldt-Jakob disease in England and Wales, 1980-1984: a case-control study of potential risk factors. J Neurol Neurosurg Psychiatry 1988;51:1113-9.
5. 5 Esmonde TFG, Will RG, Slattery JM, Knight R, Harries-Jones R, de Silva R, et al. Creutzfeldt-Jakob disease and blood transfusion. Lancet 1993;341:205-7.
6. 6 Van Dujin CM, Delasnerie-Laupretre N, Masullo C, Zerr I, deSilva R, Wientjens DPWM, et al. Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-1995. Lancet 1998;351:1081-5.
7. 7 Collins S, Law MG, Fletcher A, Boyd A, Kaldor J, Masters CL. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet 1999;353:693-7.
8. 8 Masters CL, Harris JO, Gajdusek DC, Gibbs CJ Jr, Bernoulli C, Asher DM. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 1979;5:177-88.
9. 9 Julian JA. Summary odds ratios for 2 × 2 × k tables. Version 1.0. Hamilton, Ontario: McMaster University, 1993.
10. 10 Egger M, Schneider M, Smith GD. Spurious precision? Meta-analysis of observational studies. BMJ 1998;316:140-4.
11. 11 Davanipour Z, Alter M, Sobel E, Asher D, Gajdusek DC. Creutzfeldt-Jakob disease: possible medical risk factors. Neurology 1985;35:1483-6.
12. 12 Ricketts MN, Cashman NR, Stratton EE, ElSaadany. Is Creutzfeldt-Jakob disease transmitted in blood? Emerg Infect Dis 1997;3:155-63.
13. 13 Rothman KJ, Greenland S. Matching. In: Rothman KJ, Grennland S, eds. Modern epidemiology. Philadelphia, PA: Lippincott-Raven, 1998:147-61.
14. 14 Brown P, Gibbs CJ Jr, Rodgers-Johnson P, Asher DM, Sulima MP. Bacote A, et al. Human spongiform encephalopathy: the NIH series of 300 cases of experimentally transmitted disease. Ann Neurol 1994;44:513-5.
15. 15 Evatt B, Austin H, Barnhart E, Schonberger L, Sharer L, Jones R, et al. Surveillance for Creutzfeldt-Jakob disease among persons with hemophilia. Transfusion 1998;38:817-20.
16. 16 Heye N, Hensen S, Muller N. Creutzfeldt-Jakob disease and blood transfusion. Lancet 1994;343:298-9.
17. 17 Operalski EA, Mosley JW. Pooled plasma derivatives and Creutzfeldt-Jakob disease. Lancet 1995:346:1224.
18. 18 Hill AF, Zeidler M, Ironside J, Collinge J. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 1997;349:99-100.